1987
DOI: 10.1111/j.1365-2125.1987.tb03217.x
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of ketanserin and slow‐release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta‐adrenoceptor blocker.

Abstract: 1 Ketanserin or slow-release nifedipine were added to the treatment of 24 patients with hypertension uncontrolled by a thiazide diuretic plus 13-adrenoceptor antagonist in an observer-blind, randomised parallel-group study of 6 months duration. 2 At 6 months the mean falls in supine blood pressure were for ketanserin (mean daily dose 77 mg) 7/5 mm Hg and for nifedipine (mean daily dose 62 mg) 27/10 mm Hg. The difference between the treatments was significant for systolic blood pressure (P < 0.02) and mean arte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
1997
1997

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…In vivo, ketanserin causes prolongation of the QT, interval, consistent with Class I11 antiarrhythmic activity (Waller, Solomon & Ramsay, 1987;Donnelly, Elliot, Meridith & Reid, 1987). Ketanserin may also modify reflex control of heart rate, as indicated by the absence of an appropriate increase in heart rate in response to the decrease in blood pressure caused either by acute or chronic drug administration (Fagard et al, 1984;Zabludowski, Zoccali, Isles, Murray, Robertson, Inglis, Fraser & Ball, 1984). Ketanserin may also modify reflex control of heart rate, as indicated by the absence of an appropriate increase in heart rate in response to the decrease in blood pressure caused either by acute or chronic drug administration (Fagard et al, 1984;Zabludowski, Zoccali, Isles, Murray, Robertson, Inglis, Fraser & Ball, 1984).…”
Section: Introductionmentioning
confidence: 88%
“…In vivo, ketanserin causes prolongation of the QT, interval, consistent with Class I11 antiarrhythmic activity (Waller, Solomon & Ramsay, 1987;Donnelly, Elliot, Meridith & Reid, 1987). Ketanserin may also modify reflex control of heart rate, as indicated by the absence of an appropriate increase in heart rate in response to the decrease in blood pressure caused either by acute or chronic drug administration (Fagard et al, 1984;Zabludowski, Zoccali, Isles, Murray, Robertson, Inglis, Fraser & Ball, 1984). Ketanserin may also modify reflex control of heart rate, as indicated by the absence of an appropriate increase in heart rate in response to the decrease in blood pressure caused either by acute or chronic drug administration (Fagard et al, 1984;Zabludowski, Zoccali, Isles, Murray, Robertson, Inglis, Fraser & Ball, 1984).…”
Section: Introductionmentioning
confidence: 88%